Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
8.21
-0.16 (-1.91%)
May 26, 2026, 4:00 PM EDT - Market closed
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $446.79 million as of May 26, 2026. Its market cap has decreased by -6.05% in one year.
Market Cap
446.79M
Enterprise Value
153.32M
1-Year Change
-6.05%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $446.79M, an increase of 13.59%. That is a compound annual growth rate of 8.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 455.50M | -68.95% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 481.47M |
| Adlai Nortye | 476.80M |
| Shattuck Labs | 467.75M |
| Eupraxia Pharmaceuticals | 458.60M |
| Ocugen | 453.62M |
| Autolus Therapeutics | 452.44M |
| 4D Molecular Therapeutics | 449.58M |
| Neurogene | 437.87M |